Dupont and Seegene to jointly develop highly multiplexed assays for food safety testing
In our previous blog post, we discussed the evolution of pathogen testing for food safety and the increasing need for multiplexing to be able to analyze for more than one pathogen at a time.
The vast majority of diagnostic companies participating in food safety pathogen testing currently provide single analyte solutions. Pall’s GeneDisk is one of the few offerings well suited to multiplex analysis.
As a further indication of the changing market, DuPont and Seegene announced on Thursday they will begin working jointly to develop new, highly multiplexed assays for foodborne pathogen detection. Seegene is a leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics.
By leveraging these novel technologies, we can advance from the current ‘one test, one pathogen’ approach to a ‘one test, many pathogens’ paradigm.
As pointed out by Seegene founder and CEO, Jong-Yoon Chun, “By leveraging these novel technologies, we can advance from the current ‘one test, one pathogen’ approach to a ‘one test, many pathogens’ paradigm.”
It will be interesting to watch how well the market adopts these multiplexing solutions and as a result, how the other diagnostic companies respond.
For example you can buy medications that fights bacterial infections. These medicaments will not treat several infection such as the common cold. Some pharmacies offer to their consumers Viagra. Possibly you know about price of viagra or viagra price. Medicines, like Viagra, sure, is going to change your life. Also known as impotency is defined as the failure to maintain an erection suitable for intercourse. Currently for men of any age, it can be an early warning symptom for earnest illnesses, so it’s essential for your overall heartiness, not just your sexual relationship, to see a sex therapist if you experience erection malfunction. Why it happen? What kinds of professionals treat sexual health problems in men?